- Nectin-4-directed Antibodies
- Accession Number
Monoclonal antibodies directed towards nectin-4.
Drug Drug Description Enfortumab vedotin An antibody-drug conjugate comprised of a fully human monoclonal antibody and microtubule-disrupting chemotherapeutic agent used in the treatment of advanced or metastatic urothelial cancer.
- Drugs & Drug Targets
Drug Target Type Enfortumab vedotin Cytochrome P450 3A4 enzyme Enfortumab vedotin Nectin-4 target Enfortumab vedotin P-glycoprotein 1 transporter